Oligo:Ab conjugates
an application guide

© Innova Biosciences ltd. 2013. All rights reserved
Tom Speedy, Corporate Business Manager, Innova Biosciences (UK)
With an academic background in aquatic toxicology, Tom moved into
the diagnostics industry as an R&D Scientist with a UK based forensic
toxicology/drug testing company. He spent 7 years developing a
number of successful products, including being part of the team that
developed a saliva based drugs of abuse test for roadside and POC
testing that won the Queens Award for Innovation. Tom now manages
the corporate business for Innova Biosciences, working with
diagnostics, pharma, biotech, R&D and contract research companies
globally.
Jessica Alexander, VP Specialty Manufacturing and Services
Integrated DNA Technologies (Coralville, IA, USA)

Ms. Alexander graduated with a B.S degree in
Chemistry from the University of Iowa in 1997. Five
days after her graduation she began working for IDT
and has happily made oligos ever since. She oversees
manufacturing operations for modified nucleic acids
and GMP services.

© Innova Biosciences ltd. 2013. All rights reserved
IDT Oligos + Thunder-Link® Conjugation Kit

© Innova Biosciences ltd. 2013. All rights reserved
Integrated  DNA  Technologies  (IDT)  is  the  world’s  largest  supplier  of  custom  
nucleic acids

Key Operating Statistics










>80,000 active customers
>42,000 oligos ordered per day
>2,800 orders shipped per day
>95% orders entered over the web
> 270,000 web site visits per month
(117,000 unique visitors)
> 85,000 phone calls per year
> 23,000 web chats per year
29 global sales professionals
>750 Employees

© Innova Biosciences ltd. 2013. All rights reserved
IDT Facility Locations

Coralville, IA (Headquarters)
• 14,300 square meters
• Global Infrastructure, Production and
support offices
• ISO 9001:2008 certified
• 3,100 square feet, ISO 13485:2003 and
FDA-registered clean room

Skokie, IL
•Administrative and Financial
Office

Leuven, Belgium
• 2,010 square meters
• ISO 9001:2008 certified
• Eurozone & Middle East Production and

support

San Diego, CA
• 1,654 square meters
• ISO:9001:2008 certified
• Next Day production for
Western United States

Singapore
• 560 square meters
• Asia Market Production and
Support

© Innova Biosciences ltd. 2013. All rights reserved
How to Order an Oligo

© Innova Biosciences ltd. 2013. All rights reserved
How to Design an Oligo

Standard sequence motifs to avoid
• Minimize homopolymers (e.g. CCCCCCC)
• 5’  Amino  or  Thiol  modification  is  slightly  
favored  over  3’  positions
• Avoid G-quadruplexes

© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3’

© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC 3’
START HERE

100–175 µm
particle size
Electron microscope image

© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle
Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle

Cycle #1

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle

Cycle #1

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle

Cycle #1

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle

Cycle #1

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle

Cycle #1

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

The synthesis cycle
requires between
3 and 8 minutes.

Coupling of
next base

Synthesis
Cycle

Cycle #1

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5’  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle

Cycle #2

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5ʹ′  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

Coupling of
next base

Synthesis
Cycle

Cycle #3

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
How to Synthesize an Oligo

5ʹ′  GCACTTCAGGCTCCTGGGCC  3ʹ′

Unmasking of growth
protecting
group

A 20nt oligo can
be synthesized in
one hour.

Coupling of
next base

Synthesis
Cycle

Cycle #19

Capping of
coupling failures

Oxidizing
internucleotide
bond
© Innova Biosciences ltd. 2013. All rights reserved
Coupling Efficiency vs. Full-Length Product
100%
90%

Full-Length Product (%)

80%
70%

60%
50%

99.25% - IDT Standard Oligos

40%

98.5% - Industry Standard

30%
20%
10%
0%
10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
Oligo Length (nt)

© Innova Biosciences ltd. 2013. All rights reserved
Coupling Efficiency vs. Full-Length Product
100%
90%

Full-Length Product (%)

80%
70%

60%
50%

99.25% - IDT Standard Oligos

40%

98.5% - Industry Standard

30%
20%
10%
0%
10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
Oligo Length (nt)

© Innova Biosciences ltd. 2013. All rights reserved
5ʹ′  ATCTGACTATGACTGACTGACTGACAGACTACTGACTGACTATCTGACTGA
TCTGCAACACGCAAGGTCGGCGAT-Amino  3ʹ′
Before HPLC Purification

After HPLC Purification

62.7% Target Sequence

98.4% Target Sequence
© Innova Biosciences ltd. 2013. All rights reserved
Amino and Thiol Modifiers

5ʹ′  Amino  Modifier

5ʹ′  Thiol  Modifier

© Innova Biosciences ltd. 2013. All rights reserved
Amino and Thiol Modifiers – Molecular Dust Mops
(Strong Nucleophiles)

5ʹ′  Amino  Modifier

5ʹ′  Thiol  Modifier

© Innova Biosciences ltd. 2013. All rights reserved
5ʹ′  Amino  – GTGGATCTGCGCACTTCAGGCTCCTGGGCA  3ʹ′
Before HPLC Purification

70.8% Target Sequence
© Innova Biosciences ltd. 2013. All rights reserved
5ʹ′ Amino – GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′
Before HPLC Purification

70.8% Target Sequence
© Innova Biosciences ltd. 2013. All rights reserved
5ʹ′ Amino – GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′
Before HPLC Purification

Target Sequence

Blocked Amino Modifier

70.8% Target Sequence
8.8% Blocked Amino Modifier
© Innova Biosciences ltd. 2013. All rights reserved
5ʹ′ Amino – GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′ (MW=9394.1Da)
Electrospray Ionization Mass Spec (ESI-MS) – “Molecular  Ruler”
Target Sequence

Mass(Da)
9394.2
9421.8
9447.5

Intensity Delta Mass %Relative
9.27E+04
0
100
9.58E+03
27.6
10.32
2.19E+03
53.3
2.36

%Total
88.74
9.16
2.1

Identity
Target Mass
Blocked Amino
Blocked Amino

Blocked Amino Modifier

© Innova Biosciences ltd. 2013. All rights reserved
5ʹ′ Amino – GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′
Before HPLC Purification

After HPLC Purification

70.8% Target Sequence

94.4% Target Sequence
© Innova Biosciences ltd. 2013. All rights reserved
IDT Oligos + Thunder-Link® Conjugation Kit

© Innova Biosciences ltd. 2013. All rights reserved
1. Introduction
2. Traditional Immunoassays
3. Improving on colorimetric assays
4. Conjugating oligonucleotides to antibodies
5. Applications using oligonucleotide:antibody conjugates

© Innova Biosciences ltd. 2013. All rights reserved
Introduction
2002

Founded, Cambridge UK

2004

Assay services (pharmaceuticals)

2005

Custom antibody labelling

2006

First Lightning-Link® conjugation kit launched

2009

Oligonucleotide  conjugation  systems  (‘Proactive’)

2010

Nanoparticle R&D projects initiated

2012

InnovaCoat® Gold kit launched; ISO9001 achieved

2013

Thunder-Link® kit launched
© Innova Biosciences ltd. 2013. All rights reserved
4 main product categories:

Introduction

• Lightning-Link®: enables labeling of biomolecules, with
just 30 seconds hands-on time, to a wide range of
enzymes, fluorescent dyes, biotin & streptavidin
• InnovaCoat®: range of gold nanoparticle conjugation kits
including different particle sizes and surface chemistries
• Thunder-Link®: facilitates conjugation of oligonucleotides
to antibodies, proteins or gold nanoparticles
• Phosphate detection: non-radioactive colorimetric assays
with unparalleled stability
© Innova Biosciences ltd. 2013. All rights reserved
Traditional Immunoassays
1. Antibody specific for target antigen

SANDWICH
DIRECT

© Innova Biosciences ltd. 2013. All rights reserved
Traditional Immunoassays
1. Antibody specific for target antigen
2. Suitable visualisation method – e.g.
enzyme, fluorescent dye, nanoparticle

SANDWICH

DIRECT

© Innova Biosciences ltd. 2013. All rights reserved
Traditional Immunoassays
ELISA

Lateral Flow

© Innova Biosciences ltd. 2013. All rights reserved
Traditional Immunoassays
ELISA
Detection Limits

µg to pg

Amount of starting
material required

µl

• Can be used to detect a variety of protein and
hapten targets
• Linear signal and endpoint detection
• Established technology
• Tolerates a variety of sample matrices and
contaminants
© Innova Biosciences ltd. 2013. All rights reserved
Improving on colorimetric detection

ELISA
Detection Limits
Amount of starting
material required

Oligo-linked immunosorbent
assay

µg to pg

pg to fg

µl

pl

Combines the specificity of antibodies with the amplification power of PCR
© Innova Biosciences ltd. 2013. All rights reserved
Improving on colorimetric detection
Oligo-linked immunosorbent
assay
Detection Limits

pg to fg

Amount of
starting material
required

pl

• Combines the specificity of antibodies and the
benefits of immunoassay technology, with the
amplification power of qPCR
• Exponential signal and real time detection
• High sensitivity requires high quality reagents
• Tolerates a variety of sample matrices and
contaminants
© Innova Biosciences ltd. 2013. All rights reserved
Conjugating oligonucleotides to antibodies
The quality and sensitivity of the assay is directly related to the quality of the
reagents, therefore:
• Oligonucleotide based assays require high quality oligonucleotides
• The conjugate must NOT contain fragments of oligonucleotide
• The conjugate must NOT contain unbound oligonucleotide
Traditional techniques for conjugating antibodies to oligonucleotides are costly,
time consuming and require expert knowledge
Several methods have been developed although they tend to be very complex,
unreliable and often result in the cross linking
© Innova Biosciences ltd. 2013. All rights reserved
Conjugating oligonucleotides to antibodies
To overcome these issues, the Thunder-Link® conjugation
system has been designed to facilitate the generation of
antibody-oligonucleotide conjugates
Furthermore:
• The inclusion of positive controls enables the
end user to confirm that the conjugation
chemistry is working correctly.
• Technology is unidirectional and thus only
allows formation of antibody-oligonucleotide
complexes and never antibody-antibody or
oligonucleotide-oligonucleotide.
© Innova Biosciences ltd. 2013. All rights reserved
Conjugating oligonucleotides to antibodies

© Innova Biosciences ltd. 2013. All rights reserved
Conjugating oligonucleotides to antibodies
A

B

C

D

E

Non-Reduced antibody

Banding is more often seen
with mAbs than pAbs

© Innova Biosciences ltd. 2013. All rights reserved
Conjugating oligonucleotides to antibodies
Protein

DNA

Higher order
conjugates
H chain-oligo
conjugate
H

L

L chain-oligo
conjugate

Reducing gel
© Innova Biosciences ltd. 2013. All rights reserved
© Innova Biosciences ltd. 2013. All rights reserved
Applications using oligonucleotide:antibody conjugates
• ImmunoPCR assays
• Proximity Ligation Assays
• Proximity Extension Assays
• 3DNA Technology in Lateral Flow

• 3DNA Technology in Cellular Targeting
© Innova Biosciences ltd. 2013. All rights reserved
© Innova Biosciences ltd. 2013. All rights reserved
Applications using oligonucleotide:antibody conjugates
The number of publications discussing ImmunoPCR (Pubmed)

No of occurrences

100

75
50

25
0
2003

2005

2007

2009

2011

2013

Year
© Innova Biosciences ltd. 2013. All rights reserved
ImmunoPCR

Sano, T., Smith, C. and Cantor, C., 1992. Immuno-PCR: Very Sensitive Antigen
Detection by Means of Specific Antibody-DNA Conjugates. Published by the
American Association for the Advancement of Science.
© Innova Biosciences ltd. 2013. All rights reserved
A New Tool for Paleomicrobiology:
The Plague Paradigm

ImmunoPCR

• Degradation of DNA limits ability to detect
ancient infections
• ImmunoPCR against Yersinia pestis can
detect protein conc. 70 times lower than
standard ELISA (0.74ng compared to 50ng
cutoff)
• 34 teeth from mass graves of plague
victims and 10 negative teeth were tested
• ELISA detected 3 of 34 +ves (1 false +ve)
• PCR detected 10 of 34 +ves
• iPCR detected 14 of 34 +ves

Malou N, Tran T-N-N, Nappez C, Signoli M, et al. (2012) Immuno-PCR - A New Tool for Paleomicrobiology: The Plague
Paradigm. PLoS ONE 7(2): e31744. doi:10.1371/journal.pone.0031744
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031744
© Innova Biosciences ltd. 2013. All rights reserved
Proximity Ligation Assays

© Innova Biosciences ltd. 2013. All rights reserved
Proximity Extension Assays

© Innova Biosciences ltd. 2013. All rights reserved
Proximity Extension Assays

© Innova Biosciences ltd. 2013. All rights reserved
Proximity Extension Assays

Conventional immunoassays: cross-reactivity due to unspecific binding of antibodies
limits the degree of multiplexing.

© Innova Biosciences ltd. 2013. All rights reserved
Proximity Extension Assays

Proseek Multiplex: unique DNA oligo sequences report only matched DNA-pairs (e.g.
1A+1B). Cross-reactive events are not detected.

© Innova Biosciences ltd. 2013. All rights reserved
3DNA Technology in Lateral Flow
Highly biotinylated 3DNA is customized
with specific detection antibody-oligo
conjugates. Materials are dried in a
Lateral flow Point-of-Care Test.

3DNA
Figure 2: 3DNA® Dendrimer with multiple
targeting antibodies and hundreds of labels

© Innova Biosciences ltd. 2013. All rights reserved
3DNA Technology in Lateral Flow
3DNA Assay

Reference Assay
40nm streptavidin-gold
nanoparticles bind to biotinylated
detection antibody

SA

SA
SA

SA

SA

Multiple 40nm streptavidin-gold
nanoparticles bind to ~1000 biotin
labels on 3DNA with
detection antibody conjugates
SA
SA

SA
SA

SA
SA

SA
SA

SA

© Innova Biosciences ltd. 2013. All rights reserved
3DNA Technology in Cellular Staining
Fluorescent 3DNA customized with transferrin receptor antibodyoligonucleotide conjugates used for HepG2 cell staining

Cy3 3DNA
(no targeting; no cell staining)

Cy3 3DNA hybridized with transferrin receptor
antibody-oligo conjugate (lovely cell staining)
© Innova Biosciences ltd. 2013. All rights reserved
IDT Oligos + Thunder-Link® Conjugation Kit

© Innova Biosciences ltd. 2013. All rights reserved
Innova Biosciences Ltd.
Babraham Research  Campus,  
Cambridge, UK,
CB22 3AT

www.innovabiosciences.com
Lightning-Link® is a registered trademark of Innova Biosciences
DyLight® is a registered trademark of Thermo Fisher Scientific Inc. and its subsidiaries

© Innova Biosciences ltd. 2013. All rights reserved

Oligo:Antibody Conjugates—An Application Guide

  • 1.
    Oligo:Ab conjugates an applicationguide © Innova Biosciences ltd. 2013. All rights reserved
  • 2.
    Tom Speedy, CorporateBusiness Manager, Innova Biosciences (UK) With an academic background in aquatic toxicology, Tom moved into the diagnostics industry as an R&D Scientist with a UK based forensic toxicology/drug testing company. He spent 7 years developing a number of successful products, including being part of the team that developed a saliva based drugs of abuse test for roadside and POC testing that won the Queens Award for Innovation. Tom now manages the corporate business for Innova Biosciences, working with diagnostics, pharma, biotech, R&D and contract research companies globally. Jessica Alexander, VP Specialty Manufacturing and Services Integrated DNA Technologies (Coralville, IA, USA) Ms. Alexander graduated with a B.S degree in Chemistry from the University of Iowa in 1997. Five days after her graduation she began working for IDT and has happily made oligos ever since. She oversees manufacturing operations for modified nucleic acids and GMP services. © Innova Biosciences ltd. 2013. All rights reserved
  • 3.
    IDT Oligos +Thunder-Link® Conjugation Kit © Innova Biosciences ltd. 2013. All rights reserved
  • 4.
    Integrated  DNA  Technologies (IDT)  is  the  world’s  largest  supplier  of  custom   nucleic acids Key Operating Statistics          >80,000 active customers >42,000 oligos ordered per day >2,800 orders shipped per day >95% orders entered over the web > 270,000 web site visits per month (117,000 unique visitors) > 85,000 phone calls per year > 23,000 web chats per year 29 global sales professionals >750 Employees © Innova Biosciences ltd. 2013. All rights reserved
  • 5.
    IDT Facility Locations Coralville,IA (Headquarters) • 14,300 square meters • Global Infrastructure, Production and support offices • ISO 9001:2008 certified • 3,100 square feet, ISO 13485:2003 and FDA-registered clean room Skokie, IL •Administrative and Financial Office Leuven, Belgium • 2,010 square meters • ISO 9001:2008 certified • Eurozone & Middle East Production and support San Diego, CA • 1,654 square meters • ISO:9001:2008 certified • Next Day production for Western United States Singapore • 560 square meters • Asia Market Production and Support © Innova Biosciences ltd. 2013. All rights reserved
  • 6.
    How to Orderan Oligo © Innova Biosciences ltd. 2013. All rights reserved
  • 7.
    How to Designan Oligo Standard sequence motifs to avoid • Minimize homopolymers (e.g. CCCCCCC) • 5’  Amino  or  Thiol  modification  is  slightly   favored  over  3’  positions • Avoid G-quadruplexes © Innova Biosciences ltd. 2013. All rights reserved
  • 8.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3’ © Innova Biosciences ltd. 2013. All rights reserved
  • 9.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC 3’ START HERE 100–175 µm particle size Electron microscope image © Innova Biosciences ltd. 2013. All rights reserved
  • 10.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 11.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Cycle #1 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 12.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Cycle #1 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 13.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Cycle #1 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 14.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Cycle #1 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 15.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Cycle #1 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 16.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group The synthesis cycle requires between 3 and 8 minutes. Coupling of next base Synthesis Cycle Cycle #1 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 17.
    How to Synthesizean Oligo 5’  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Cycle #2 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 18.
    How to Synthesizean Oligo 5ʹ′  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group Coupling of next base Synthesis Cycle Cycle #3 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 19.
    How to Synthesizean Oligo 5ʹ′  GCACTTCAGGCTCCTGGGCC  3ʹ′ Unmasking of growth protecting group A 20nt oligo can be synthesized in one hour. Coupling of next base Synthesis Cycle Cycle #19 Capping of coupling failures Oxidizing internucleotide bond © Innova Biosciences ltd. 2013. All rights reserved
  • 20.
    Coupling Efficiency vs.Full-Length Product 100% 90% Full-Length Product (%) 80% 70% 60% 50% 99.25% - IDT Standard Oligos 40% 98.5% - Industry Standard 30% 20% 10% 0% 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 Oligo Length (nt) © Innova Biosciences ltd. 2013. All rights reserved
  • 21.
    Coupling Efficiency vs.Full-Length Product 100% 90% Full-Length Product (%) 80% 70% 60% 50% 99.25% - IDT Standard Oligos 40% 98.5% - Industry Standard 30% 20% 10% 0% 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 Oligo Length (nt) © Innova Biosciences ltd. 2013. All rights reserved
  • 22.
    5ʹ′  ATCTGACTATGACTGACTGACTGACAGACTACTGACTGACTATCTGACTGA TCTGCAACACGCAAGGTCGGCGAT-Amino  3ʹ′ BeforeHPLC Purification After HPLC Purification 62.7% Target Sequence 98.4% Target Sequence © Innova Biosciences ltd. 2013. All rights reserved
  • 23.
    Amino and ThiolModifiers 5ʹ′  Amino  Modifier 5ʹ′  Thiol  Modifier © Innova Biosciences ltd. 2013. All rights reserved
  • 24.
    Amino and ThiolModifiers – Molecular Dust Mops (Strong Nucleophiles) 5ʹ′  Amino  Modifier 5ʹ′  Thiol  Modifier © Innova Biosciences ltd. 2013. All rights reserved
  • 25.
    5ʹ′  Amino  –GTGGATCTGCGCACTTCAGGCTCCTGGGCA  3ʹ′ Before HPLC Purification 70.8% Target Sequence © Innova Biosciences ltd. 2013. All rights reserved
  • 26.
    5ʹ′ Amino –GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′ Before HPLC Purification 70.8% Target Sequence © Innova Biosciences ltd. 2013. All rights reserved
  • 27.
    5ʹ′ Amino –GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′ Before HPLC Purification Target Sequence Blocked Amino Modifier 70.8% Target Sequence 8.8% Blocked Amino Modifier © Innova Biosciences ltd. 2013. All rights reserved
  • 28.
    5ʹ′ Amino –GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′ (MW=9394.1Da) Electrospray Ionization Mass Spec (ESI-MS) – “Molecular  Ruler” Target Sequence Mass(Da) 9394.2 9421.8 9447.5 Intensity Delta Mass %Relative 9.27E+04 0 100 9.58E+03 27.6 10.32 2.19E+03 53.3 2.36 %Total 88.74 9.16 2.1 Identity Target Mass Blocked Amino Blocked Amino Blocked Amino Modifier © Innova Biosciences ltd. 2013. All rights reserved
  • 29.
    5ʹ′ Amino –GTGGATCTGCGCACTTCAGGCTCCTGGGCA 3ʹ′ Before HPLC Purification After HPLC Purification 70.8% Target Sequence 94.4% Target Sequence © Innova Biosciences ltd. 2013. All rights reserved
  • 30.
    IDT Oligos +Thunder-Link® Conjugation Kit © Innova Biosciences ltd. 2013. All rights reserved
  • 31.
    1. Introduction 2. TraditionalImmunoassays 3. Improving on colorimetric assays 4. Conjugating oligonucleotides to antibodies 5. Applications using oligonucleotide:antibody conjugates © Innova Biosciences ltd. 2013. All rights reserved
  • 32.
    Introduction 2002 Founded, Cambridge UK 2004 Assayservices (pharmaceuticals) 2005 Custom antibody labelling 2006 First Lightning-Link® conjugation kit launched 2009 Oligonucleotide  conjugation  systems  (‘Proactive’) 2010 Nanoparticle R&D projects initiated 2012 InnovaCoat® Gold kit launched; ISO9001 achieved 2013 Thunder-Link® kit launched © Innova Biosciences ltd. 2013. All rights reserved
  • 33.
    4 main productcategories: Introduction • Lightning-Link®: enables labeling of biomolecules, with just 30 seconds hands-on time, to a wide range of enzymes, fluorescent dyes, biotin & streptavidin • InnovaCoat®: range of gold nanoparticle conjugation kits including different particle sizes and surface chemistries • Thunder-Link®: facilitates conjugation of oligonucleotides to antibodies, proteins or gold nanoparticles • Phosphate detection: non-radioactive colorimetric assays with unparalleled stability © Innova Biosciences ltd. 2013. All rights reserved
  • 34.
    Traditional Immunoassays 1. Antibodyspecific for target antigen SANDWICH DIRECT © Innova Biosciences ltd. 2013. All rights reserved
  • 35.
    Traditional Immunoassays 1. Antibodyspecific for target antigen 2. Suitable visualisation method – e.g. enzyme, fluorescent dye, nanoparticle SANDWICH DIRECT © Innova Biosciences ltd. 2013. All rights reserved
  • 36.
    Traditional Immunoassays ELISA Lateral Flow ©Innova Biosciences ltd. 2013. All rights reserved
  • 37.
    Traditional Immunoassays ELISA Detection Limits µgto pg Amount of starting material required µl • Can be used to detect a variety of protein and hapten targets • Linear signal and endpoint detection • Established technology • Tolerates a variety of sample matrices and contaminants © Innova Biosciences ltd. 2013. All rights reserved
  • 38.
    Improving on colorimetricdetection ELISA Detection Limits Amount of starting material required Oligo-linked immunosorbent assay µg to pg pg to fg µl pl Combines the specificity of antibodies with the amplification power of PCR © Innova Biosciences ltd. 2013. All rights reserved
  • 39.
    Improving on colorimetricdetection Oligo-linked immunosorbent assay Detection Limits pg to fg Amount of starting material required pl • Combines the specificity of antibodies and the benefits of immunoassay technology, with the amplification power of qPCR • Exponential signal and real time detection • High sensitivity requires high quality reagents • Tolerates a variety of sample matrices and contaminants © Innova Biosciences ltd. 2013. All rights reserved
  • 40.
    Conjugating oligonucleotides toantibodies The quality and sensitivity of the assay is directly related to the quality of the reagents, therefore: • Oligonucleotide based assays require high quality oligonucleotides • The conjugate must NOT contain fragments of oligonucleotide • The conjugate must NOT contain unbound oligonucleotide Traditional techniques for conjugating antibodies to oligonucleotides are costly, time consuming and require expert knowledge Several methods have been developed although they tend to be very complex, unreliable and often result in the cross linking © Innova Biosciences ltd. 2013. All rights reserved
  • 41.
    Conjugating oligonucleotides toantibodies To overcome these issues, the Thunder-Link® conjugation system has been designed to facilitate the generation of antibody-oligonucleotide conjugates Furthermore: • The inclusion of positive controls enables the end user to confirm that the conjugation chemistry is working correctly. • Technology is unidirectional and thus only allows formation of antibody-oligonucleotide complexes and never antibody-antibody or oligonucleotide-oligonucleotide. © Innova Biosciences ltd. 2013. All rights reserved
  • 42.
    Conjugating oligonucleotides toantibodies © Innova Biosciences ltd. 2013. All rights reserved
  • 43.
    Conjugating oligonucleotides toantibodies A B C D E Non-Reduced antibody Banding is more often seen with mAbs than pAbs © Innova Biosciences ltd. 2013. All rights reserved
  • 44.
    Conjugating oligonucleotides toantibodies Protein DNA Higher order conjugates H chain-oligo conjugate H L L chain-oligo conjugate Reducing gel © Innova Biosciences ltd. 2013. All rights reserved
  • 45.
    © Innova Biosciencesltd. 2013. All rights reserved
  • 46.
    Applications using oligonucleotide:antibodyconjugates • ImmunoPCR assays • Proximity Ligation Assays • Proximity Extension Assays • 3DNA Technology in Lateral Flow • 3DNA Technology in Cellular Targeting © Innova Biosciences ltd. 2013. All rights reserved
  • 47.
    © Innova Biosciencesltd. 2013. All rights reserved
  • 48.
    Applications using oligonucleotide:antibodyconjugates The number of publications discussing ImmunoPCR (Pubmed) No of occurrences 100 75 50 25 0 2003 2005 2007 2009 2011 2013 Year © Innova Biosciences ltd. 2013. All rights reserved
  • 49.
    ImmunoPCR Sano, T., Smith,C. and Cantor, C., 1992. Immuno-PCR: Very Sensitive Antigen Detection by Means of Specific Antibody-DNA Conjugates. Published by the American Association for the Advancement of Science. © Innova Biosciences ltd. 2013. All rights reserved
  • 50.
    A New Toolfor Paleomicrobiology: The Plague Paradigm ImmunoPCR • Degradation of DNA limits ability to detect ancient infections • ImmunoPCR against Yersinia pestis can detect protein conc. 70 times lower than standard ELISA (0.74ng compared to 50ng cutoff) • 34 teeth from mass graves of plague victims and 10 negative teeth were tested • ELISA detected 3 of 34 +ves (1 false +ve) • PCR detected 10 of 34 +ves • iPCR detected 14 of 34 +ves Malou N, Tran T-N-N, Nappez C, Signoli M, et al. (2012) Immuno-PCR - A New Tool for Paleomicrobiology: The Plague Paradigm. PLoS ONE 7(2): e31744. doi:10.1371/journal.pone.0031744 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031744 © Innova Biosciences ltd. 2013. All rights reserved
  • 51.
    Proximity Ligation Assays ©Innova Biosciences ltd. 2013. All rights reserved
  • 52.
    Proximity Extension Assays ©Innova Biosciences ltd. 2013. All rights reserved
  • 53.
    Proximity Extension Assays ©Innova Biosciences ltd. 2013. All rights reserved
  • 54.
    Proximity Extension Assays Conventionalimmunoassays: cross-reactivity due to unspecific binding of antibodies limits the degree of multiplexing. © Innova Biosciences ltd. 2013. All rights reserved
  • 55.
    Proximity Extension Assays ProseekMultiplex: unique DNA oligo sequences report only matched DNA-pairs (e.g. 1A+1B). Cross-reactive events are not detected. © Innova Biosciences ltd. 2013. All rights reserved
  • 56.
    3DNA Technology inLateral Flow Highly biotinylated 3DNA is customized with specific detection antibody-oligo conjugates. Materials are dried in a Lateral flow Point-of-Care Test. 3DNA Figure 2: 3DNA® Dendrimer with multiple targeting antibodies and hundreds of labels © Innova Biosciences ltd. 2013. All rights reserved
  • 57.
    3DNA Technology inLateral Flow 3DNA Assay Reference Assay 40nm streptavidin-gold nanoparticles bind to biotinylated detection antibody SA SA SA SA SA Multiple 40nm streptavidin-gold nanoparticles bind to ~1000 biotin labels on 3DNA with detection antibody conjugates SA SA SA SA SA SA SA SA SA © Innova Biosciences ltd. 2013. All rights reserved
  • 58.
    3DNA Technology inCellular Staining Fluorescent 3DNA customized with transferrin receptor antibodyoligonucleotide conjugates used for HepG2 cell staining Cy3 3DNA (no targeting; no cell staining) Cy3 3DNA hybridized with transferrin receptor antibody-oligo conjugate (lovely cell staining) © Innova Biosciences ltd. 2013. All rights reserved
  • 59.
    IDT Oligos +Thunder-Link® Conjugation Kit © Innova Biosciences ltd. 2013. All rights reserved
  • 60.
    Innova Biosciences Ltd. Babraham Research Campus,   Cambridge, UK, CB22 3AT www.innovabiosciences.com Lightning-Link® is a registered trademark of Innova Biosciences DyLight® is a registered trademark of Thermo Fisher Scientific Inc. and its subsidiaries © Innova Biosciences ltd. 2013. All rights reserved